ArticleFrontiers in neuroscience2025
Geometric and dosimetric evaluation of auto-segmentation of brain arteriovenous malformations using multimodal imaging in stereotactic radiosurgery.
Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Optimizing radiation dose to protect white matter (WM) tracts during stereotactic radiosurgery (SRS) of brain arteriovenous malformations (bAVMs) necessitates the integration of diffusion tensor imaging (DTI)-based WM tractography to delineate WM tracts and establish dose constraints. Conventional manual delineation of perilesional targets demonstrated significant operational inefficiency, primarily attributed to the complex structural interdigitation between pathological vasculature and eloquent brain areas. Purpose: This study aimed to develop a two-stage deep learning (DL) method that combines a two-dimensional (2D) U-Net detection-aided and three-dimensional (3D) self-attention segmentation model for automatic bAVM segmentation. This method focuses on improving efficiency in clinical practice while protecting WM tracts using multimodal imaging and WM tractography in SRS. Methods: We analyzed imaging data from 191 patients who underwent CyberKnife-based SRS at Huashan Hospital, Fudan University, with bAVMs closely adjacent to WM tracts. A total of 153 patients were used to construct a two-stage DL model to segment the bAVMs on multimodal imaging and WM tractography, while the remaining 38 patients were utilized to validate the model's performance. We introduced spatial and channel attention modules in the U-Net variant, along with a versatile "Attentional ResBlock," achieving parameter efficiency through cross-dimensional interaction while preserving model fidelity. The accuracy of the auto-segmented contours is evaluated using geometric indices and dosimetric endpoints. Results: Our proposed model demonstrated superior segmentation performance, achieving a dice similarity coefficient (DSC) of 0.84 ± 0.05, sensitivity of 0.92 ± 0.09, and F2-score of 0.79 ± 0.08. Furthermore, it attained a low Hausdorff distance (4.55 ± 1.14 mm) and mean surface distance (0.53 ± 0.08 mm), indicating exceptional boundary delineation precision. The difference in the proportion of WM tracts within the target region between manual and our automated contours is minimal (0.08 ± 0.13). Meanwhile, strong concordance is observed between auto-segmented and manually contoured targets across the majority of dosimetric endpoints, with a mean difference of 0.46 Gy. The received dose of WM tracts in the two comparison plans also has an acceptable representation of dosimetric parameters ( Conclusion: The reliable bAVM automated-segmentation method has been validated and may support SRS planning for bAVMs and thus avoid neurological sequelae after SRS in considering WM tracts protection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.